News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Allergy Therapeutics Ltd. Release: Board Change And Clinical Update
November 22, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Allergy Therapeutics (‘ATp’) today announces the following update on the progress of its extensive clinical development programme:
Twitter
LinkedIn
Facebook
Email
Print
People
Europe
MORE ON THIS TOPIC
Duchenne muscular dystrophy
Dyne gets early 2027 decision date for Duchenne therapy, analysts expect ‘smooth’ review
July 21, 2026
·
2 min read
·
Tristan Manalac
IPO
Axiom plans Hong Kong IPO, hoping to carve new path for US biotechs
July 21, 2026
·
3 min read
·
Gabrielle Masson
Psychedelics
Lilly’s AtaiBeckley buy validates space as Big Pharma takes note of psychedelics
July 20, 2026
·
3 min read
·
Heather McKenzie
IPO
2026 IPO class blooms again as BlossomHill, Latigo set sights on Nasdaq
July 20, 2026
·
2 min read
·
Tristan Manalac
